These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O. Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):460-6. PubMed ID: 23553523 [Abstract] [Full Text] [Related]
27. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation. Snipelisky D, Ray JC, Ung R, Duart M, Kauffman C, Kusumoto F. J Interv Card Electrophysiol; 2014 Dec; 41(3):231-6. PubMed ID: 25380703 [Abstract] [Full Text] [Related]
31. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation. Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T. Intern Med; 2015 Dec; 54(10):1167-73. PubMed ID: 25986252 [Abstract] [Full Text] [Related]
33. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies. Brunetti ND, Tricarico L, Tilz RR, Heeger CH, De Gennaro L, Correale M, Ieva R, Di Biase M, Rillig A, Metzner A, Santoro F. Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786 [Abstract] [Full Text] [Related]
34. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Yasaka M, Minematsu K, Yamaguchi T. Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841 [Abstract] [Full Text] [Related]
35. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W. Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [Abstract] [Full Text] [Related]
37. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation. Kang F, Ma Y, Cai A, Cheng X, Liu P, Kuang J, Mai Z, Mai W. Am J Cardiol; 2021 Mar 01; 142():74-82. PubMed ID: 33307015 [Abstract] [Full Text] [Related]
39. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Nagao T, Inden Y, Yanagisawa S, Kato H, Ishikawa S, Okumura S, Mizutani Y, Ito T, Yamamoto T, Yoshida N, Hirai M, Murohara T. Heart Rhythm; 2015 Sep 01; 12(9):1972-8. PubMed ID: 25881495 [Abstract] [Full Text] [Related]